Archive: 25/06/2015

New drug squashes cancer's last-ditch efforts to survive

As a tumor grows, its cancerous cells ramp up an energy-harvesting process to support its hasty development. This process, called autophagy, is normally used by a cell to recycle damaged organelles and proteins, but is also ...

Jun 25, 2015

0

300

Targeting nerve endings to curb allergic asthma

Current asthma medications, which work by suppressing inflammatory signaling by immune cells or by dilating the airways, can stop working over time. A study from Boston Children's Hospital, Brigham and Women's Hospital, and ...

Jun 25, 2015

0

44

Proof-of-concept study to assess impact of glycemic variability

(HealthDay)—A proof-of-concept study will be able to examine the contribution of glycemic variability to outcomes of type 2 diabetes, according to a report published online June 11 in Diabetes Care.

Jun 25, 2015

0

5

Cellulitis often misdiagnosed in inpatient setting

(HealthDay)—Cellulitis is frequently misdiagnosed in the inpatient setting, according to research published in the July issue of the Journal of the American Academy of Dermatology.

Jun 25, 2015

0

3

New class of compounds shrinks pancreatic cancer tumours and prevents regrowth

Scientists from UCL (University College London) have designed a chemical compound that has reduced the growth of pancreatic cancer tumours by 80 percent in treated mice.

Jun 25, 2015

0

4263

Age-adjusted comorbidity score stratifies mortality in prostate CA

(HealthDay)—An age-adjusted prostate cancer-specific comorbidity index (PCCI) can stratify the risk of long-term nonprostate cancer-related mortality, according to a study published in the July issue of The Journal of Urology.

Jun 25, 2015

0

7

British court ruling backs patent protecting Lilly's Alimta

Eli Lilly received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.

Jun 25, 2015

FDA reviewing safety of Essure birth control implant

Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

Jun 25, 2015